Canada once boasted world-class biomanufacturing capacity, particularly in vaccine production. A dose of the measles, mumps and rubella (MMR) vaccination awaits the next patient during a vaccine clinic at Southwestern Public Health in St. Thomas, Ont., on March 2025.
THE CANADIAN PRESS/Geoff Robins
As Canada faces renewed trade tensions with the United States, investing in domestic biomanufacturing could strengthen both national security and economic independence.
